Everyone gets sick, and drastic health problems call for more drastic treatment. That’s partly why several top-rated biotech stocks in today’s IBD 50 list have held up well despite recent market pressue. Alexion Pharmaceuticals (ALXN), the fourth stock in today’s screen, develops treatments for neurological and other disorders. The company has two years of strong EPS and sales gains under its belt, driven by Soliris, its blockbuster drug that
Many Internet and social-media companies face a particular set of challenges — rising competition, adapting to the shift toward mobile use and concerns about keeping users on their sites amid tremendous hype and distractions. Today’s Screen of the Day, Top Fundamentals, focuses on Internet stocks that have 3-year EPS growth rate of 25% or more. While the stocks in today’s screen have wavered around their key 50-day moving average in recent weeks,
In recent weeks, China has lowered benchmark interest rates, started a program that will insure individual bank deposits and debuted a program that enables traders on the Shanghai and Hong Kong exchanges to buy and sell on either one — all moves intended to ward off further economic slowdown. Whether China’s measures will help the nation long-term is unclear. On Tuesday, for instance, the Shanghai Composite Index saw its biggest plunge since 2009,